Recent advancements in the CLL treatment landscape have prompted members of the CARE™ Faculty to discuss how these developments have affected the practice of KOLs across the globe. CARE™ Faculty recently spoke with Dr. Matthew Davids to explore how data released in 2019 have impacted CLL practice.
This issue of the CARE™ Global Interview Series includes content on:
1. Front-line CLL
- ELEVATE TN
2. Relapsed/Refractory CLL
- TRANSCEND CLL 004
While CARE™ Content is typically framed from a Canadian Perspective, this series provides insights from global leaders. Content is presented in the format in which it was discussed and is a paraphrase of interview dialogue.